Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.73
-0.1000-2.07%
Post-market: 4.730.00000.00%19:30 EDT
Volume:226.21K
Turnover:1.07M
Market Cap:269.65M
PE:-4.25
High:4.94
Open:4.87
Low:4.64
Close:4.83
52wk High:5.50
52wk Low:1.68
Shares:57.01M
Float Shares:28.74M
Volume Ratio:0.82
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1137
EPS(LYR):-0.3328
ROE:-44.98%
ROA:-28.70%
PB:1.47
PE(LYR):-14.21

Loading ...

Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 22

Whitehawk Therapeutics exapnds antibody drug conjugate pipeline

TIPRANKS
·
May 22

Whitehawk to present HWK-007 Phase 1 trial design at ASCO meeting

Reuters
·
May 22

Whitehawk enrolls Phase 1 dose-escalation trial for PTK7-targeted ADC HWK-007

Reuters
·
May 22

WhiteHawk Therapeutics Inc - to Submit Ind Applications for Multiple Programs Over Next 12-24 Months

THOMSON REUTERS
·
May 22

WhiteHawk Therapeutics Expands ADC Pipeline With New Option Agreement for Use of Cpt113 Linker-Payload

THOMSON REUTERS
·
May 22

Whitehawk Therapeutics CEO joins TD Cowen Oncology Innovation Summit fireside chat

Reuters
·
May 20

Whitehawk Therapeutics CEO to join Stifel Virtual Targeted Oncology Forum fireside chat

Reuters
·
May 15

May 2026's Promising Penny Stocks

Simply Wall St.
·
May 14

Whitehawk Therapeutics announces $87.5M private placement

TIPRANKS
·
May 14

BRIEF-Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing

Reuters
·
May 13

Whitehawk Therapeutics prices USD 87.5 million PIPE at USD 3.92 per share

Reuters
·
May 13

WhiteHawk Therapeutics Announces $87.5M Private Placement Equity Financing

THOMSON REUTERS
·
May 13

Natural gas mineral firm WhiteHawk reveals sevenfold revenue surge in US IPO filing

Reuters
·
May 11

Oppenheimer Sticks to Its Buy Rating for Whitehawk Therapeutics (WHWK)

TIPRANKS
·
May 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), Prime Medicine, Inc. (PRME) and Argenx Se (ARGX)

TIPRANKS
·
May 08

Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Whitehawk Therapeutics posts corporate deck outlining three-asset antibody-drug conjugate pipeline

Reuters
·
May 07

Whitehawk Q1 net loss turns to USD 22.2 million

Reuters
·
May 07

WhiteHawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

THOMSON REUTERS
·
May 07